Zimmer Biomet Holdings ROE 2006-2019 | ZBH

Current and historical return on equity (ROE) values for Zimmer Biomet Holdings (ZBH) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Zimmer Biomet Holdings ROE for the three months ending March 31, 2019 was 13.24%.
Zimmer Biomet Holdings ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-03-31 $-0.31B $11.54B -2.62%
2018-12-31 $-0.38B $11.28B -3.19%
2018-09-30 $1.75B $12.22B 14.61%
2018-06-30 $1.69B $12.04B 14.62%
2018-03-31 $1.69B $12.00B 15.19%
2017-12-31 $1.81B $11.74B 17.10%
2017-09-30 $0.65B $10.45B 6.47%
2017-06-30 $0.71B $10.28B 7.19%
2017-03-31 $0.50B $9.93B 5.11%
2016-12-31 $0.31B $9.67B 3.18%
2016-09-30 $0.36B $9.75B 3.75%
2016-06-30 $0.23B $9.55B 2.32%
2016-03-31 $0.08B $9.66B 0.85%
2015-12-31 $0.15B $9.89B 1.60%
2015-09-30 $0.17B $9.99B 2.02%
2015-06-30 $0.32B $10.13B 4.28%
2015-03-31 $0.67B $6.58B 10.26%
2014-12-31 $0.72B $6.55B 11.19%
2014-09-30 $0.83B $6.54B 12.96%
2014-06-30 $0.81B $6.45B 12.86%
2014-03-31 $0.78B $6.24B 12.75%
2013-12-31 $0.78B $6.30B 12.98%
2013-09-30 $0.68B $6.14B 11.49%
2013-06-30 $0.70B $5.89B 12.05%
2013-03-31 $0.77B $5.71B 13.23%
2012-12-31 $0.76B $5.87B 13.11%
2012-09-30 $0.76B $5.83B 13.38%
2012-06-30 $0.77B $5.71B 13.76%
2012-03-31 $0.76B $5.66B 13.38%
2011-12-31 $0.76B $5.52B 13.25%
2011-09-30 $0.64B $5.61B 11.01%
2011-06-30 $0.64B $6.02B 10.89%
2011-03-31 $0.60B $5.86B 10.37%
2010-12-31 $0.60B $5.77B 10.36%
2010-09-30 $0.72B $5.82B 12.52%
2010-06-30 $0.68B $5.74B 11.72%
2010-03-31 $0.72B $5.71B 12.45%
2009-12-31 $0.72B $5.64B 12.48%
2009-09-30 $0.73B $5.98B 12.70%
2009-06-30 $0.80B $5.81B 14.05%
2009-03-31 $0.81B $5.56B 14.54%
2008-12-31 $0.85B $5.65B 15.10%
2008-09-30 $0.95B $5.62B 16.96%
2008-06-30 $0.78B $5.51B 14.15%
2008-03-31 $0.78B $5.71B 14.38%
2007-12-31 $0.77B $5.45B 14.67%
2007-09-30 $0.76B $5.25B 14.68%
2007-06-30 $0.89B $5.28B 17.75%
2007-03-31 $0.86B $5.12B 17.47%
2006-12-31 $0.84B $4.92B 17.09%
2006-09-30 $0.79B $4.80B 16.37%
2006-06-30 $0.78B $4.90B 16.33%
2006-03-31 $0.77B $4.92B 16.64%
2005-12-31 $0.73B $4.68B 16.64%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $24.447B $7.933B
Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The company design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Zimmer Biomet Holdings, Inc., formerly known as Zimmer Holdings, Inc., is based in Warsaw, United States.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $148.773B 28.88
Medtronic (MDT) Ireland $132.439B 18.92
Stryker (SYK) United States $74.804B 26.70
Boston Scientific (BSX) United States $57.935B 27.77
Baxter (BAX) United States $41.482B 26.15
Smith & Nephew SNATS (SNN) United Kingdom $19.056B 0.00
ResMed (RMD) United States $17.285B 33.03
Canopy Growth (CGC) Canada $14.734B 0.00
Bio-Rad Laboratories (BIO) United States $9.176B 48.65
Aurora Cannabis (ACB) Canada $7.585B 74.80
Insulet (PODD) United States $7.205B 524.91
Hill-Rom Holdings (HRC) United States $7.115B 21.57
Perrigo (PRGO) Ireland $6.034B 10.20
Haemonetics (HAE) United States $6.002B 48.99
GW Pharmaceuticals (GWPH) United Kingdom $5.303B 0.00
ICU Medical (ICUI) United States $5.078B 30.30
Hutchison China MediTech (HCM) China $3.822B 0.00
Neogen (NEOG) United States $3.283B 53.38
NuVasive (NUVA) United States $3.047B 24.89
Agios Pharmaceuticals (AGIO) United States $3.019B 0.00
National Vision Holdings (EYE) United States $2.421B 51.58
Quidel (QDEL) United States $2.341B 24.30
Aphria (APHA) $1.690B 0.00
Cardiovascular Systems (CSII) United States $1.513B 869.00
HEXO (HEXO) $1.479B 0.00
Phibro Animal Health (PAHC) United States $1.209B 18.11
AtriCure (ATRC) United States $1.181B 0.00
VAREX IMAGING (VREX) United States $1.121B 23.79
Lantheus Holdings (LNTH) United States $1.092B 29.01
OrganiGram Holdings (OGI) Canada $0.973B 0.00
NanoString Technologies (NSTG) United States $0.945B 0.00
PetIQ (PETQ) United States $0.927B 22.51
Quanterix (QTRX) United States $0.859B 0.00
MacroGenics (MGNX) United States $0.817B 0.00
Omeros (OMER) United States $0.816B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.753B 21.12
Cerus (CERS) United States $0.678B 0.00
TG Therapeutics (TGTX) United States $0.676B 0.00
Surmodics (SRDX) United States $0.585B 85.04
OraSure Technologies (OSUR) United States $0.549B 25.26
LeMaitre Vascular (LMAT) United States $0.536B 25.93
Meridian Bioscience (VIVO) United States $0.499B 15.26
Evolus (EOLS) United States $0.374B 0.00
Vapotherm (VAPO) United States $0.363B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.359B 0.00
Zynex (ZYXI) United States $0.335B 34.60
BioLife Solutions (BLFS) United States $0.331B 103.53
Utah Medical Products (UTMD) United States $0.328B 22.71
Bovie Medical (APYX) United States $0.226B 0.00
Cytosorbents (CTSO) United States $0.212B 0.00
Owens & Minor (OMI) United States $0.184B 3.91
Rockwell Medical (RMTI) United States $0.180B 0.00
Chimerix (CMRX) United States $0.169B 0.00
Fonar (FONR) United States $0.135B 7.11
Female Health (VERU) United States $0.131B 0.00
Chembio Diagnostics (CEMI) United States $0.105B 0.00
BRAINSWAY LTD (BWAY) Israel $0.102B 0.00
Neurotrope (NTRP) United States $0.091B 0.00
InfuSystems Holdings (INFU) United States $0.090B 0.00
United-Guardian (UG) United States $0.088B 19.35
Surface Oncology (SURF) United States $0.088B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.062B 0.00
ImmuCell (ICCC) United States $0.049B 0.00
Trinity Biotech (TRIB) Ireland $0.039B 13.67
Senestech (SNES) United States $0.035B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.033B 0.00
GUARDION HEALTH (GHSI) United States $0.032B 0.00
Cellectar Biosciences (CLRB) United States $0.021B 0.00
Valeritas Holdings (VLRX) United States $0.016B 0.00
Myomo (MYO) United States $0.014B 0.00
Capricor Therapeutics (CAPR) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.007B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.005B 3.93